. Overexpression of Egr-1 in adipose does not change the metabolic parameters. a) Construct vector for generation of adipose-specific Egr-1 transgenic mice. aP2 promoter was used to drive rat Egr-1 cDNA expression in adipose tissues. b) Two lines of wild-type (Wt) and Egr-1 transgenic (Tg) mice were obtained and the Egr-1 expression in white adipose tissues (WAT), brown adipose tissues (BAT and muscle were detected by western blot. GAPDH was served as loading control. c&d) Both body weight and food intake in adult, male wild-type and transgenic mice were measured. n=10. e&f) both glucose tolerance (GTT) and insulin tolerance (ITT) tests were performed by injection (i.p.) with 2 g/kg of glucose or 0.75 IU/kg of insulin. The blood glucose levels were recorded at indicated time after injection. Data were presented as mean±SD, n=7. Adenovirus-infected 3T3-L1 cells were treated with DMI for 7 days and subjected to Oil O staining (d). e) Mouse embryonic fibroblasts isolated from Egr-1+/+, Egr-1+/-and Egr-1-/-mice were induced with DMI for 9 days and subjected to Oil O staining. f) Western blot confirmed Egr-1 is not expressed in the MEFs from Egr-1-/-mice. Actin was served as loading control. g&h) NAB2 (a Egr-1 inhibitor) stable cell line and control 3T3-L1 cell line were induced by different combinations of inducer (D: dexamethasone; M: IBMX; I: insulin; R: rosiglitazone) for 7 days and subjected Oil O staining. Overexpression of NAB2 was confirmed by Western blot (g). All experiments were repeated three times and showed similar results.
